Optimizing Dosing Strategies in Oral Iron Supplementation
NCT06238895
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Iron Deficiencies
Iron Deficiency Anemia
Iron Deficiency Anemia Treatment
Interventions
DRUG:
Tardyferon
Sponsor
Luzerner Kantonsspital